Johnson & Johnson
JNJ
#25
Rank
C$729.90 B
Marketcap
C$303.22
Share price
0.05%
Change (1 day)
43.01%
Change (1 year)

Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.

Revenue for Johnson & Johnson (JNJ)

Revenue in 2026 (TTM): C$132.80 Billion

According to Johnson & Johnson's latest financial reports the company's current revenue (TTM ) is C$131.95 Billion. In 2025 the company made a revenue of C$128.99 Billion an increase over the revenue in the year 2024 that were of C$127.45 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Johnson & Johnson from 1996 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) C$132.80 B2.95%
2025 C$128.99 B1.21%
2024 C$127.45 B12.84%
2023 C$112.95 B-8.68%
2022 C$123.68 B3.49%
2021 C$119.51 B13.49%
2020 C$105.30 B-1.75%
2019 C$107.17 B-3.56%
2018 C$111.12 B15.62%
2017 C$96.11 B-0.51%
2016 C$96.60 B-0.61%
2015 C$97.20 B12.69%
2014 C$86.25 B13.63%
2013 C$75.91 B13.56%
2012 C$66.84 B1.06%
2011 C$66.14 B7.45%
2010 C$61.56 B-5.47%
2009 C$65.12 B-15.97%
2008 C$77.50 B27.17%
2007 C$60.94 B-1.83%
2006 C$62.08 B5.57%
2005 C$58.81 B3.41%
2004 C$56.86 B4.73%
2003 C$54.30 B-5.28%
2002 C$57.32 B10.75%
2001 C$51.76 B16.99%
2000 C$44.24 B10.26%
1999 C$40.13 B10.33%
1998 C$36.37 B12.5%
1997 C$32.33 B9.18%
1996 C$29.61 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novartis
NVS
C$77.47 B-41.29%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$86.69 B-34.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$61.80 B-53.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
C$48.58 B-63.18%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
C$98.93 B-25.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$75.94 B-42.44%๐Ÿ‡ซ๐Ÿ‡ท France
Gilead Sciences
GILD
C$40.31 B-69.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
C$34.39 B-73.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$90.05 B-31.75%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$60.47 B-54.17%๐Ÿ‡ฌ๐Ÿ‡ง UK